iRhythm Technologies, Inc. (IRTC)
Market Cap | 2.36B |
Revenue (ttm) | 560.03M |
Net Income (ttm) | -150.66M |
Shares Out | 31.30M |
EPS (ttm) | -4.85 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 491,423 |
Open | 76.09 |
Previous Close | 76.86 |
Day's Range | 75.02 - 76.96 |
52-Week Range | 55.92 - 124.12 |
Beta | 1.23 |
Analysts | Strong Buy |
Price Target | 107.78 (+42.81%) |
Earnings Date | Oct 30, 2024 |
About IRTC
iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ... [Read more]
Financial Performance
In 2023, iRhythm Technologies's revenue was $492.68 million, an increase of 19.90% compared to the previous year's $410.92 million. Losses were -$123.41 million, 6.24% more than in 2022.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price forecast is $107.78, which is an increase of 42.81% from the latest price.
News
iRhythm Data Presented at the American Heart Association 2024 Scientific Sessions Reinforce Clinical and Health Economic Value of Zio Long-Term Continuous Monitoring
Five new studies span three focus areas for LTCM devices: digital engagement and patient satisfaction, arrhythmia patterns during sleep and activity, and the potential health care resource and economi...
iRhythm Technologies to Participate in the Wolfe Research 2024 Healthcare Conference
SAN FRANCISCO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - Presi...
iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients
iRhythm Technologies Announces Third Quarter 2024 Financial Results
SAN FRANCISCO, Oct. 30, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve...
Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent dise...
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
On Monday, the FDA approved iRhythm Technologies, Inc.'s IRTC 510(k) submission related to prior design changes to the Zio AT device via letter to file.
iRhythm Technologies Receives FDA 510(k) Clearance for Design Updates Previously Made to Its Zio® AT Device
Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients Zio AT...
iRhythm Technologies to Report Third Quarter 2024 Financial Results on October 30, 2024
SAN FRANCISCO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...
Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm
PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company's long-term sharehold...
iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
SAN FRANCISCO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...
iRhythm Unveils Data Demonstrating Superior Real-World Performance of Next-Generation Zio® Monitor at HRX 2024 Meeting
iRhythm's next-generation Zio ® monitor demonstrated longer wear duration and analyzable time compared to the prior generation Zio ® XT device. Longer wear duration and analyzable time may further imp...
iRhythm Technologies Announces Results of GUARD-AF Trial
GUARD-AF trial results presented at European Society of Cardiology (ESC) Congress 2024 Leveraging iRhythm's Zio ® patch-based long-term continuous monitoring (LTCM), GUARD-AF is the largest randomized...
iRhythm Technologies Expands Global Reach with the Launch of Zio® Cardiac Arrhythmia Monitoring Service in Austria, the Netherlands, Switzerland, and Spain
SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
iRhythm Technologies to Participate in Upcoming Investor Conferences in September
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
iRhythm Technologies, Inc. (IRTC) Q2 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Conference Call August 1, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - Presid...
iRhythm Technologies Announces Chief Financial Officer Transition
SAN FRANCISCO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc . (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preve...
iRhythm Technologies to Report Second Quarter 2024 Financial Results on August 1, 2024
SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict...
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
iRhythm Technologies Achieves Significant Operational Milestone with Launch of Initial Phase of Manufacturing Automation
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
iRhythm Technologies to Present at the 2024 Truist Securities MedTech Conference
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
iRhythm Technologies to Present at the William Blair 44th Annual Growth Stock Conference
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent ...
iRhythm Technologies, Inc. (IRTC) Q1 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President and CEO Brice B...
iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...
FINAL DEADLINE TODAY: The Schall Law Firm Encourages Investors in iRhythm Technologies, Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / April 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against iRhythm Technologies, Inc. ("iRhy...